Evidence map›Paper›PMID 38548268›Full record

ArticleThe American journal of pathology2024

TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.

Amanda S Pellowe, Michelle J Wu, Tae-Yun Kang, Tracy D Chung, Adrian Ledesma-Mendoza, Erica Herzog, Andre Levchenko, Ian Odell, John Varga, Anjelica L Gonzalez

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Amanda S PelloweDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Michelle J WuDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Tae-Yun KangDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Tracy D ChungDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Adrian Ledesma-MendozaDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Erica HerzogSection of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New Haven, Connecticut.
Andre LevchenkoDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Ian OdellDepartment of Dermatology, Yale University School of Medicine, New Haven, Connecticut.
John VargaMichigan Scleroderma Program, Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Anjelica L GonzalezDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut. Electronic address: anjelica.gonzalez@yale.edu.
Yale University · USUniversity of Michigan · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Noradrenergic mechanisms of IPFR01HL163984 · NHLBI · YALE UNIVERSITY · PI Erica L Herzog · 2022 to 2026
$3.7M
Macrophage driven, profibrotic adrenergic nerve remodeling in SSc-ILDR01HL152677 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2020 to 2023
$2.4M
Neuroimmune Molecules in Scleroderma Lung FibrosisR01HL125850 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2016 to 2019
$1.7M
Pericyte reprogramming in fibrosisR01EB033917 · NIBIB · YALE UNIVERSITY · PI GONZALEZ, ANJELICA · 2023 to 2024
$971k
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL125850NHLBI NIH HHS R01 HL152677NHLBI NIH HHS R01 HL163984NIBIB NIH HHS R01 EB033917
6 · The paper itself

Abstract

Interactions between endothelial cells (ECs) and mural pericytes (PCs) are critical in maintaining the stability and function of the microvascular wall. Abnormal interactions between these two cell types are a hallmark of progressive fibrotic diseases such as systemic sclerosis (also known as scleroderma). However, the role of PCs in signaling microvascular dysfunction remains underexplored. We hypothesized that integrin-matrix interactions contribute to PC migration from the vascular wall and conversion into interstitial myofibroblasts. Herein, pro-inflammatory tumor necrosis factor α (TNFα) or a fibrotic growth factor [transforming growth factor β1 (TGF-β1)] were used to evaluate human PC inflammatory and fibrotic phenotypes by assessing their migration, matrix deposition, integrin expression, and subsequent effects on endothelial dysfunction. Both TNFα and TGF-β1 treatment altered integrin expression and matrix protein deposition, but only fibrotic TGF-β1 drove PC migration in an integrin-dependent manner. In addition, integrin-dependent PC migration was correlated to changes in EC angiopoietin-2 levels, a marker of vascular instability. Finally, there was evidence of changes in vascular stability corresponding to disease state in human systemic sclerosis skin. This work shows that TNFα and TGF-β1 induce changes in PC integrin expression and matrix deposition that facilitate migration and reduce vascular stability, providing evidence that microvascular destabilization can be an early indicator of tissue fibrosis.

Indexed as

Cell MovementFibrosisIntegrinsPericytesScleroderma, SystemicTransforming Growth Factor beta1Endothelial CellsHumansMicrovesselsSkinTumor Necrosis Factor-alphaIntegrinsTransforming Growth Factor beta1Tumor Necrosis Factor-alpha

Identifiers

PMID38548268
PMCPMC11220919
OpenAlexW4393187887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.